Who wants second‐line, palliative chemotherapy?
- 28 August 2001
- journal article
- research article
- Published by Wiley in Psycho-Oncology
- Vol. 10 (5) , 410-418
Abstract
This paper reports on a study designed to measure the value attached to second‐line, palliative chemotherapy by people with advanced cancer, compared with the value healthy people assume they would attach if they had cancer and to assess reasons for accepting or declining treatment. Subjects comprised 92 people with cancer, 76 healthy control subjects, 60 medical oncologists, 128 clinical oncologists, 72 palliative care physicians, 58 general practitioners and 59 qualified nurses working within oncology. Using a questionnaire presenting two typical but imaginary treatment scenarios, subjects indicated whether treatment would be acceptable to them and, if so, what minimum chance and duration of benefit would make treatment worthwhile. Demographic and social data were also collected. Patients accepted a lower chance of benefit than all other groups. Although the minimum worthwhile duration of benefit was more evenly spread, patients choosing lower time values were over‐represented. These results were consistent even when treatment involved greater toxicity. The conclusion drawn from this study is that people with advanced cancer are more willing to accept second‐line chemotherapy with a lower chance and shorter duration of benefit than others may imagine. Health care professionals must recognize this when discussing treatment options with patients. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Perceptions of Cisplatin-Related Toxicity among Ovarian Cancer Patients and Gynecologic OncologistsGynecologic Oncology, 1998
- Treatment choices in advanced cancer: issues and perspectivesEuropean Journal of Cancer Care, 1998
- Trading treatment toxicity for survival in locally advanced non-small cell lung cancer.Journal of Clinical Oncology, 1997
- Living wills: would sick people change their minds?Postgraduate Medical Journal, 1994
- Cost effectiveness in the treatment of advanced solid tumoursEuropean Journal of Cancer, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Quality and cost in the palliative care of cancerBritish Journal of Cancer, 1992
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990
- Cardiopulmonary Resuscitation in the AgedNew England Journal of Medicine, 1984
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983